These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12389079)

  • 1. Intrasplenic transplantation of syngenic hepatocytes modified by IFN-gamma gene ameliorates hepatic fibrosis in rats.
    Song E; Chen J; Wang K; Zhang H; Su F; Wang M; Heemann U
    Transpl Int; 2002 Oct; 15(9-10):472-8. PubMed ID: 12389079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrasplenic transplantation of IL-18 gene-modified hepatocytes: an effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response.
    Zhang LH; Pan JP; Yao HP; Sun WJ; Xia DJ; Wang QQ; He L; Wang J; Cao X
    Gene Ther; 2001 Sep; 8(17):1333-42. PubMed ID: 11571570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
    Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
    J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of IFN-gamma gene-modified hepatocytes on TGF-beta 1 and its receptor in mice infected with Schistosoma japonicum].
    Zhang L; Yao H; Cao X; Yu Y; Chen H; Li M
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):330-3. PubMed ID: 12563723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of interferon alpha improves dimethylnitrosamine-induced liver cirrhosis in rat model.
    Suzuki K; Aoki K; Ohnami S; Yoshida K; Kazui T; Kato N; Inoue K; Kohara M; Yoshida T
    Gene Ther; 2003 May; 10(9):765-73. PubMed ID: 12704415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J; Zhang L; Yao H; Cao X
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
    Garcia-Bañuelos J; Siller-Lopez F; Miranda A; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
    Gene Ther; 2002 Jan; 9(2):127-34. PubMed ID: 11857071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice.
    Zhang L; Mi J; Yu Y; Yao H; Chen H; Li M; Cao X
    Parasite Immunol; 2001 Jan; 23(1):11-7. PubMed ID: 11136473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation?
    Kim WH; Lee JH; Han SU; Wang HJ; Kim MW
    Hepatogastroenterology; 1998; 45(24):2425-9. PubMed ID: 9951937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a plasmid expressing antisense tissue inhibitor of metalloproteinase-1 on liver fibrosis in rats.
    Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
    Chin Med J (Engl); 2005 Feb; 118(3):192-7. PubMed ID: 15740646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice.
    Chen C; Zhang J; Li J; Huang J; Yang C; Huang G; Shi J
    Liver Int; 2004 Dec; 24(6):679-86. PubMed ID: 15566521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
    Sun WY; Wei W; Wu L; Gui SY; Wang H
    J Ethnopharmacol; 2007 Jul; 112(3):514-23. PubMed ID: 17574357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of gene-transfected bone marrow-derived liver stem cell transplantation on accumulation of extracellular matrix in rats with liver fibrosis].
    Sun C; Li DG; Chen YW; Chen YW; Wang BC
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2685-9. PubMed ID: 19080687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes.
    Cai J; Ito M; Nagata H; Westerman KA; Lafleur D; Chowdhury JR; Leboulch P; Fox IJ
    Hepatology; 2002 Aug; 36(2):386-94. PubMed ID: 12143047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis.
    Gagandeep S; Rajvanshi P; Sokhi RP; Slehria S; Palestro CJ; Bhargava KK; Gupta S
    J Pathol; 2000 May; 191(1):78-85. PubMed ID: 10767723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation.
    Nagata H; Ito M; Cai J; Edge AS; Platt JL; Fox IJ
    Gastroenterology; 2003 Feb; 124(2):422-31. PubMed ID: 12557148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF.
    Bueno M; Salgado S; Beas-Zárate C; Armendariz-Borunda J
    J Gene Med; 2006 Nov; 8(11):1291-9. PubMed ID: 16958060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.